Article may be outdated

This article is 2 days old. Some details may have changed since publication.

Hacker News·2 min read·medium

Launch HN: RonanRX (YC S26) – Personalized Peptides and GLP-1s

L
lloydarmbrust
Launch HN: RonanRX (YC S26) – Personalized Peptides and GLP-1s
AI Summary

RonanRX is a Y Combinator-backed startup offering personalized GLP-1 weight loss medication plans managed by physicians and pharmacists. The service aims to replace 'one-size-fits-all' dosing with customized titration schedules to improve patient outcomes and manage side effects.

Why it matters

The rise of personalized telehealth services for weight loss medications reflects a broader trend in healthcare toward patient-specific treatment plans and direct-to-consumer medical services.

Dive DeeperCreate a free account to unlock

One-size dosing wasn't built for your body. Your plan should be.

A physician reviews your history and sets your dose, your titration, and a patient-specific adjunct for your body, not a one-size label. A licensed pharmacist at your selected pharmacy verifies and releases only what the prescriber orders. It starts as a simple text, with no charge to find out if it is right for you.

Your data is private & secure HIPAA compliant, encrypted end to end Your medicine is safe to use By licensed U.S. pharmacies I want help reaching my goals I want to optimize what I'm taking How would you like to start?

Continue reading on Headlinne

Create a free account to read the full article.

Read full article →
healthstartupsbusiness

Get smarter about the news

Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.

Create free account

Already have an account? Sign in